THE LONG-TERM, REAL-WORLD EFFECTIVENESS AND SAFETY OF LOMITAPIDE IN HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLAEMIA (HOFH): NINE-YEAR DATA FROM THE LOMITAPIDE OBSERVATIONAL WORLDWIDE EVALUATION REGISTRY (LOWER)

被引：0
|
作者：
Blom, Dirk [1 ]
Underberg, James [2 ]
Cannon, Christopher [3 ]
Larrey, Dominique [4 ]
Makris, Lukas [5 ]
O'Brien, Sallyann [6 ]
机构：
[1] Univ Cape Town, Dept Med, Cape Town, South Africa
[2] NYU Grossman Sch Med, Dept Med, New York, NY USA
[3] Harvard Med Sch, Brigham & Womens Hosp, Heart & Vasc Ctr, Boston, MA USA
[4] Univ Hosp Montpellier, Montpellier, France
[5] Stathmi Inc, New Hope, PA USA
[6] Chiesi Pharamceut SpA, Dublin, Ireland
来源：
ATHEROSCLEROSIS | 2024年 / 395卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
O052
引用
收藏
页数：2
相关论文
共 50 条
  • [1] THE LONG-TERM, REAL-WORLD EFFECTIVENESS AND SAFETY OF LOMITAPIDE IN HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLAEMIA (HOFH): NINE-YEAR DATA FROM THE LOMITAPIDE OBSERVATIONAL WORLDWIDE EVALUATION REGISTRY (LOWER)
    Blom, Dirk
    Cegla, Jaimini
    Underberg, James
    Cannon, Christopher P.
    Larrey, Dominique
    Makris, Lukas
    O'Brien, Sallyann
    ATHEROSCLEROSIS PLUS, 2024, 57 : 1 - 2
  • [2] LONG-TERM SAFETY AND EFFICACY OF LOMITAPIDE IN PATIENTS WITH HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA: THREE-YEAR DATA FROM THE LOMITAPIDE OBSERVATIONAL WORLDWIDE EVALUATION REGISTRY (LOWER)
    Underberg, James
    Cannon, Christopher
    Larrey, Dominique
    Makris, Lukas
    Jurecka, Agnieszka
    Blom, Dirk
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (11) : 168 - 168
  • [3] LONG-TERM SAFETY AND EFFICACY OF LOMITAPIDE IN PATIENTS WITH HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA: FIVE-YEAR DATA FROM THE LOMITAPIDE OBSERVATIONAL WORLDWIDE EVALUATION REGISTRY (LOWER)
    Underberg, James A.
    Cannon, Christopher P.
    Larrey, Dominique
    Makris, Lukas
    Phillips, Helen
    Blom, Dirk
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (11) : 1992 - 1992
  • [4] Long-term safety and efficacy of lomitapide in patients with homozygous familial hypercholesterolemia: Five-year data from the Lomitapide Observational Worldwide Evaluation Registry (LOWER)
    Underberg, James A.
    Cannon, Christopher P.
    Larrey, Dominique
    Makris, Lukas
    Blom, Dirk
    Phillips, Helen
    JOURNAL OF CLINICAL LIPIDOLOGY, 2020, 14 (06) : 807 - 817
  • [5] Global Real-World Data on the Use of Lomitapide in Treating Homozygous Familial Hypercholesterolemia: The Lomitapide Observational Worldwide Evaluation Registry (LOWER), Two-Year Data
    Underberg, James
    Cannon, Christopher
    Larrey, Dominique
    Makris, Lukas
    Schwamlein, Charles
    Phillips, Helen
    Bloeden, LeAnne
    Blom, Dirk
    CIRCULATION, 2016, 134
  • [6] Global Real-World Data on the Use of Lomitapide in Treating Homozygous Familial Hypercholesterolemia: The Lomitapide Observational Worldwide Evaluation Registry (LOWER), Two-Year Data
    Underberg, James
    Cannon, Christopher
    Larrey, Dominique
    Makris, Lukas
    Schwamlein, Charles
    Phillips, Helen
    Bloeden, LeAnne
    Blom, Dirk
    CIRCULATION, 2016, 134
  • [7] Long-termliver safety of lomitapide in patients with homozygous familial hypercholesterolemia: Three-year data from the lomitapide observational worldwide evaluation registry (LOWER)
    Larrey, D.
    Underberg, J.
    Cannon, C.
    Makris, L.
    Jurecka, A.
    Blom, D.
    JOURNAL OF HEPATOLOGY, 2018, 68 : S588 - S588
  • [8] Long-term hepatic safety of lomitapide in homozygous familial hypercholesterolaemia
    Larrey, Dominique
    D'Erasmo, Laura
    O'Brien, Sallyann
    Arca, Marcello
    Italian Working Grp Lomitapide
    LIVER INTERNATIONAL, 2023, 43 (02) : 413 - 423
  • [9] LONG-TERM EFFECTIVENESS AND SAFETY OF LOMITAPIDE: REAL-WORLD EXPERIENCE FROM ITALY IN PATIENTS WITH HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
    Suppressa, P.
    Coppola, C.
    Cocco, V.
    O'Brien, S.
    Stanzione, C.
    De Ruberto, F.
    Lannuzzo, G.
    ATHEROSCLEROSIS, 2023, 379
  • [10] LOMITAPIDE IN THE LONG-TERM REAL-WORLD MANAGEMENT OF HOFH - EFFECTIVENESS, TOLERABILITY, AND HEPATIC SAFETY DATA FROM THE PAN-EUROPEAN STUDY
    D'Erasmo, L.
    Steward, K.
    Di Costanzo, A.
    Boersma, E.
    Arca, M.
    Van Lennep, J. E. Roeters
    ATHEROSCLEROSIS, 2022, 355 : E27 - E27
12345